Aquestive Therapeutics (AQST) Preferred Dividend Payments (2017)
Aquestive Therapeutics' (AQST) quarterly Preferred Dividend Payments came in at $626000.0 in Q4 2017, little changed quarter-over-quarter from $626000.0 in Q3 2017.
Aquestive Therapeutics (AQST) Preferred Dividend Payments (2017) Analysis & Trends
Aquestive Therapeutics' Preferred Dividend Payments history runs 1 years deep, the most recent figure standing at $626000.0 for Q4 2017.
- On a quarterly basis, Preferred Dividend Payments changed N/A year-over-year to $626000.0 in Q4 2017; TTM through Dec 2018 was $626000.0, a N/A change from a year earlier, with the FY2017 full-year figure at $2.5 million, changed N/A from the prior year.
- Preferred Dividend Payments was little changed at $626000.0 in Q4 2017 per AQST's latest filing, from $626000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $626000.0 in Q3 2017 and bottomed at $615000.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Aquestive Therapeutics | 462.24 Mn | 462.24 Mn | 13.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 626,000.00 |
| Sep 30, 2017 | 626,000.00 |
| Jun 30, 2017 | 615,000.00 |